Carlin Jane D reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP, INC. director Jane D. Carlin reported an equity grant in the form of 843 shares of common stock on May 12, 2026. The award was granted at no cash cost to her and is described as restricted stock units under the company’s 2022 Long-Term Incentive Plan.
These units vest on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting. After this grant, Carlin directly holds 3,266 common shares. A footnote also notes an additional 2,306 shares held indirectly in a Rabbi Trust pursuant to deferral agreements, separate from the reported direct holdings.
HANOVER INSURANCE GROUP, INC. director Cynthia Egan reported receiving an equity award in the form of 843 shares of common stock at $0.00 per share, classified as a grant or award acquisition. This grant was issued as restricted stock units under the company’s 2022 Long-Term Incentive Plan.
The units vest on the earlier of the one-year anniversary of the grant date or the next annual meeting, and Egan has elected to defer the grant upon vesting under a deferral agreement. After this award, she directly owns 10,202 shares of common stock, and a footnote states this does not include 977 shares held indirectly in a Rabbi Trust under deferral agreements.
HANOVER INSURANCE GROUP, INC. senior vice president and principal accounting officer Patricia A. Norton-Gatto reported her initial ownership of company securities. She holds 2,440.302 shares of common stock directly, including restricted stock units that vest on the third anniversary of their grant dates.
She also holds stock options to acquire 963 shares of common stock at an exercise price of $173.5600 per share expiring on February 24, 2036, and options for 920 shares at $161.8200 per share expiring on February 25, 2035. The filing lists these as existing positions rather than new transactions.
Hanover Insurance Group Executive Vice President Denise Lowsley sold 1,062 shares of common stock in an open-market transaction. The shares were sold at a price of $188.43 per share. After this sale, she directly holds 3,882.513 Hanover Insurance Group common shares.
THG submitted a Form 144-style disclosure listing planned or recent securities transactions through a broker. The filing identifies a 99-share ESPP purchase settled in cash on 06/28/2024 and 963 shares delivered on 02/28/2025 from restricted stock vesting as compensation. The broker listed is Fidelity Brokerage Services LLC with an address in Smithfield, RI. The filing references the NYSE and a filing date of 05/08/2026.
Hanover Insurance Group Executive Vice President T. Willard Lee reported an open-market sale of 1,000 shares of Common Stock at $183.93 per share. After this transaction, Lee directly holds 5,982.373 shares. This filing reflects a single sale transaction with no derivative securities reported.
Hanover Insurance Group director Cynthia Egan sold 3,400 shares of Common Stock in an open-market transaction at $188.50 per share. After this sale, she directly holds 9,359 shares. A footnote states she also has 977 shares held indirectly, in addition to her direct holdings.
THG filed a Form 144 notice regarding the proposed sale of 1,000 shares of Common Stock through Fidelity Brokerage Services LLC. The filing lists an aggregate amount of $183,930.00 and references 34,986,787 shares (displayed) with an effective notice date of 05/04/2026. The notice records two restricted-stock vesting lots: 792 shares (02/28/2023) and 208 shares (02/26/2024), both labeled as compensation.
Fidelity Brokerage Services LLC submitted a Form 144 notifying the sale of 3,400 shares of Common Stock of THG on the NYSE. The filing lists an aggregate amount of $640,900.00 and is dated 05/01/2026. The shares represent vested restricted stock from grants dated 06/07/2016 (355), 06/02/2021 (980), 05/25/2022 (946) and 05/20/2024 (1,119).
The Hanover Insurance Group reported stronger quarterly results, with net income of $186.8 million versus $128.2 million a year earlier. Total revenues rose to $1.70 billion from $1.60 billion, driven by higher premiums and a notable increase in net investment income.
Basic earnings per share increased to $5.30 from $3.56, helped by improved current accident year underwriting results, including across Core Commercial and Specialty, and higher yields on the investment portfolio. The company also benefited from $73.8 million of net favorable prior-year reserve development.
Hanover reduced total debt to $843.8 million from $1.22 billion mainly by redeeming $375 million of senior debentures, while repurchasing about 503,000 shares for $87.5 million. Cash and cash equivalents declined to $243.5 million as operating cash generation was offset by investing and financing outflows.